Compare MO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MO | BSX |
|---|---|---|
| Founded | 1822 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8B | 93.4B |
| IPO Year | 1994 | 2010 |
| Metric | MO | BSX |
|---|---|---|
| Price | $73.32 | $44.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 22 |
| Target Price | $65.00 | ★ $93.18 |
| AVG Volume (30 Days) | 6.6M | ★ 21.1M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | ★ 6.22% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | ★ 1.30 | 0.90 |
| Revenue | ★ $23,279,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $3.49 | $11.85 |
| Revenue Next Year | $0.36 | $10.16 |
| P/E Ratio | $56.30 | ★ $49.13 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $54.70 | $43.89 |
| 52 Week High | $74.44 | $109.50 |
| Indicator | MO | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 28.43 |
| Support Level | $68.11 | N/A |
| Resistance Level | $74.20 | $50.14 |
| Average True Range (ATR) | 1.49 | 1.37 |
| MACD | 0.21 | 0.08 |
| Stochastic Oscillator | 87.86 | 4.61 |
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 40% share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev, and a 41% stake in cannabis manufacturer Cronos. In reduced-risk products, it acquired vaping company Njoy Holdings in 2023, operates a joint venture with Japan Tobacco in the heated tobacco category for the US, and sells the On brand in nicotine pouches.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.